Physician Assistant · Sacramento, CA
NPI
1891773834
Since 2006
Specialty
Physician Assistant
Code 363A00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
2951 Fulton Ave
Sacramento, CA, 95821
Phone (916) 486-7555
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.8M
10,091 prescriptions
Company payments, 2025
$7,238
From 26 companies
Medicare prescription drug claims, 2024
In 2024, the drug Antonio Z Luza prescribed most often to Medicare patients was Alprazolam, with 821 prescriptions and refills. In total Antonio Z Luza wrote 10,091 Medicare prescriptions that cost $1.8M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-09-28.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Alprazolam Generic | 821 | 846 | 99 | $6,491 |
| Clonazepam Generic | 708 | 717 | 86 | $5,009 |
| Trazodone Hcl Generic | 682 | 778 | 97 | $4,616 |
| Quetiapine Fumarate Generic | 663 | 758 | 66 | $15K |
| Buspirone Hcl Generic | 367 | 392 | 51 | $2,564 |
| Duloxetine Hcl Generic | 365 | 423 | 48 | $4,139 |
| Bupropion Xl Bupropion Hcl | 346 | 418 | 56 | $4,670 |
| Sertraline Hcl Generic | 333 | 379 | 53 | $1,172 |
| Zolpidem Tartrate Generic | 306 | 328 | 46 | $1,455 |
| Aripiprazole Generic | 301 | 343 | 36 | $16K |
| Lamotrigine Generic | 282 | 352 | 38 | $2,194 |
| Olanzapine Generic | 267 | 344 | 33 | $5,576 |
| Lorazepam Generic | 244 | 251 | 40 | $1,783 |
| Escitalopram Oxalate Generic | 240 | 300 | 36 | $1,891 |
| Hydroxyzine Pamoate Generic | 223 | 233 | 36 | $2,419 |
Brand drugs: - claims; generic drugs: 9,268 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Antonio Z Luza $7,238 ($7,238 in general payments such as food, travel and fees) from 26 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $2,166.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 16 | $2,166 |
| Neurocrine BioSciences, Inc. NBIX | 19 | $1,025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 34 | $572 |
| Vanda Pharmaceuticals Inc. VNDA | 13 | $451 |
| Teva Pharmaceuticals USA, Inc. TEVA | 16 | $421 |
| Exact Sciences Corporation EXAS | 5 | $393 |
| Janssen Pharmaceuticals, Inc JNJ | 7 | $333 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 10 | $278 |
| Lilly USA, LLC LLY | 5 | $254 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. 4578.T | 2 | $196 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.